These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8842769)

  • 1. Ethosuximide-induced lupus-like syndrome with renal involvement.
    Takeda S; Koizumi F; Takazakura E
    Intern Med; 1996 Jul; 35(7):587-91. PubMed ID: 8842769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants.
    Singsen BH; Fishman L; Hanson V
    Pediatrics; 1976 Apr; 57(4):529-34. PubMed ID: 1083501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethosuximide-associated lupus with cerebral and renal manifestations.
    Casteels K; Van Geet C; Wouters K
    Eur J Pediatr; 1998 Sep; 157(9):780. PubMed ID: 9776542
    [No Abstract]   [Full Text] [Related]  

  • 4. [Systemic lupus erythematosus induced by anticonvulsivant drug (author's transl)].
    Tor J; Rey C; Fernández-Sevilla T; Martí Vilalta JL
    Med Clin (Barc); 1979 Dec; 73(10):443-6. PubMed ID: 93671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethosuximide-induced de novo systemic lupus erythematosus with anti-double-strand DNA antibodies: a case report with definite evidence.
    Crespel A; Velizarova R; Agullo M; Gélisse P
    Epilepsia; 2009 Aug; 50(8):2003. PubMed ID: 19682032
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.
    Toyama T; Asano Y; Taniguchi T; Takahashi T; Ichimura Y; Tamaki Z; Kagami S; Mitsui H; Sato S
    Eur J Dermatol; 2017 Apr; 27(2):196-197. PubMed ID: 28026802
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-induced lupus.
    Miyasaka N
    Intern Med; 1996 Jul; 35(7):527-8. PubMed ID: 8842756
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children.
    Beernink DH; Miller JJ
    J Pediatr; 1973 Jan; 82(1):113-7. PubMed ID: 4564576
    [No Abstract]   [Full Text] [Related]  

  • 9. 50 Years Ago in TheJournal ofPediatrics: Occurrence of Systemic Lupus Erythematosus in Association with Ethosuccimide Therapy.
    Hashkes PJ
    J Pediatr; 2020 Apr; 219():53. PubMed ID: 32204806
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of drug-induced lupus].
    Lovisetto P; Mairano D; Cargnino M; Biarese V; Marchi L; Lerda R
    Recenti Prog Med; 1985 Feb; 76(2):84-6. PubMed ID: 3991975
    [No Abstract]   [Full Text] [Related]  

  • 11. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced systemic lupus erythematosus in a nine-year-old boy.
    Ansell BM
    Lupus; 1993 Jun; 2(3):193-4. PubMed ID: 8369811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus-scleroderma syndrome induced by ethosuximide.
    Teoh PC; Chan HL
    Arch Dis Child; 1975 Aug; 50(8):658-61. PubMed ID: 812426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible induction of systemic lupus erythematosus by zonisamide.
    Mutoh K; Hidaka Y; Hirose Y; Kimura M
    Pediatr Neurol; 2001 Oct; 25(4):340-3. PubMed ID: 11704407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tubulo-interstitial nephritis (TIN) with no glomerular lesions, distal renal tubular acidosis and asteatosis cutis in a patient with systemic lupus erythematosus (SLE): a case report].
    Ogura N; Baba Y; Sakai I; Taneichi K; Shibaki H
    Ryumachi; 1992 Oct; 32(5):508-14; discussion 512-3. PubMed ID: 1440088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants.
    Drory VE; Korczyn AD
    Clin Neuropharmacol; 1993 Feb; 16(1):19-29. PubMed ID: 8422654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus. Occurrence in association with ethosuximide therapy.
    Livingston S; Rodriguez H; Greene CA; Pauli LL
    JAMA; 1968 May; 204(8):731-2. PubMed ID: 4967459
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesangial proliferative lupus nephritis with podocytopathy: a special entity of lupus nephritis.
    Wang SF; Chen YH; Chen DQ; Liu ZZ; Xu F; Zeng CH; Hu WX
    Lupus; 2018 Feb; 27(2):303-311. PubMed ID: 28720048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethosuximide induced agranulocytosis.
    Imai T; Okada H; Nanba M; Kawada K; Kusaka T; Itoh S
    Brain Dev; 2003 Oct; 25(7):522-4. PubMed ID: 13129598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular complications in lupus nephritis and lupus-like syndromes.
    Seshan SV
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):687-91. PubMed ID: 11020958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.